Cardea
Cardea is a New York-based psychedelic-assisted therapy practice offering ketamine-assisted psychotherapy through its proprietary Lascaux Method to individuals, service-oriented professionals, and aspiring practitioners via sessions, facilitator training, and Jamaica retreats.
- Company typePrivate
- Founded2022
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Cardea does
Cardea is a New York City-based psychedelic-assisted therapy and transformation practice operating as Cardea LCSW PLLC. Founded in 2022 and co-led by Ross Ellenhorn (Ph.D., LICSW, author of three books on human change) and Dimitri Mugianis (harm reduction advocate with 500+ ibogaine ceremonies), the company delivers ketamine-assisted psychotherapy through its proprietary Lascaux Method, a short-term framework integrating dialogic space holding, live vibrational sound, and art-making. Services are provided in individual and group formats at a dedicated, artist-designed Ketamine Space on Canal Street, supplemented by psilocybin preparation/integration coaching, harm reduction and addiction support, and challenging-experience support. Cardea also operates multi-day retreats in Jamaica and runs a recurring Salon Series of cultural and educational events.
The business monetizes through a portfolio of professional-services offerings: group ketamine sessions at approximately $550 per session (including $100 medical fee and $100 medication), specialty sessions at $750, workshops and retreats priced $1,500-$2,300, and a flagship 5-week Lascaux Method Facilitator Training at $2,100. The go-to-market is asset-light and content-led: Cardea relies on free 30-minute consultations as the primary intake funnel, supplemented by earned media in The Guardian, Time, NY Magazine, Rolling Stone, Jacobin, and Salon, plus an owned blog, monthly email newsletter, and Instagram presence. Community is reinforced through weekly virtual integration groups, the Furthur Fund non-profit scholarship program (which has treated 90+ frontline professionals), and a growing network of Lascaux-trained facilitators. The customer base is concentrated among individuals seeking personal transformation and service-oriented professionals, with secondary demand from aspiring practitioners and wellness-seekers; all revenue is consumer-paid or training-paid, with no disclosed enterprise contracts. The company has raised a single $200,000 seed round in July 2022 and has not disclosed additional funding, revenue, or profitability metrics.
Cardea firmographics
Firmographics- Name
- Cardea
- Legal name
- Cardea LCSW PLLC
- Website
- https://cardea.net
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cardea is a New York-based psychedelic-assisted therapy practice offering ketamine-assisted psychotherapy through its proprietary Lascaux Method to individuals, service-oriented professionals, and aspiring practitioners via sessions, facilitator training, and Jamaica retreats.
- Ownership category
- akta.pro rank
Cardea industry classification
Industry- Product category
- Psychedelic-Assisted Therapy Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Outpatient Mental Health and Substance Abuse Centers (621420)
- akta.pro primary industry
- Cardiac Rehabilitation & Secondary Prevention (HLAKABAJ)
- akta.pro secondary industries
- Cardiac Rehabilitation Programs (HLAFAFAJ), Cardiopulmonary Rehabilitation (Cardiac & Pulmonary Rehab) (HSADAIAK), Cardiopulmonary Rehabilitation Therapy In-Home (HSABADAG)
Keywords
Where Cardea is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Cardea business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Supply Chain
Revenue model
- Ketamine-Assisted Therapy Sessions: Revenue from individual and group ketamine-assisted psychotherapy sessions. Includes session fees, medical evaluation fees, and medication costs. Group sessions are priced more affordably than individual sessions.
- Training and Certification Programs: Revenue from the Lascaux Method Facilitator Training program - a 5-week immersive training for psychedelic-assisted care. Includes certification for preparation and integration.
- Retreats and Workshops: Revenue from therapeutic retreats including ketamine-assisted workshops, sound bath events, and special programming like the Founder's Weekend and partnership retreats.
- Salon Series and Events: Revenue from educational and discussion events including the Cardea Salon Series featuring guest speakers. Ticket proceeds are often donated to the Furthur Fund non-profit.
- Furthur Fund Scholarships: Non-profit scholarship program providing subsidized ketamine treatments to service-oriented professionals. Supported by donations and event proceeds rather than generating direct revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Group Ketamine Session |
| Unit Pricing | Pay-as-you-go | Specialty Group Sessions (Acupuncture, Death Mindfulness) |
| Unit Pricing | Multi-year contract | IHRP Workshop (April 2025) |
| Unit Pricing | Multi-year contract | Ketamine & Meditation Retreat (March 2025) |
| Unit Pricing | Multi-year contract | Founder's Weekend of Serious Play |
| Unit Pricing | Multi-year contract | Lascaux Method Facilitator Training |
| Donation/ grant-funded | Pay-as-you-go | Guided Meditation & Sound Bath |
| Donation/ grant-funded | Pay-as-you-go | Salon Series Events |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Cardea product offering
Product offeringCore offering
Cardea is a human-centered psychedelic therapy and transformation practice that delivers ketamine-assisted psychotherapy through its proprietary Lascaux Method, offered in both individual and group formats with live vibrational sound and art-making. The practice also provides psilocybin services, psychedelic preparation and integration coaching, harm reduction coaching, facilitator training and certification programs, and organizational consulting, all anchored in a dialogic model of care.
Product overview
Cardea is a human-centered psychedelic therapy and transformation practice offering a unified portfolio of ketamine-assisted psychotherapy services. The core offering centers on The Lascaux Method—a signature dialogic model of ketamine-assisted care—delivered through individual and group sessions featuring live sound, art-making, and integration coaching. Additional offerings include psilocybin services, coaching certifications, facilitator training programs, and the Furthur Fund non-profit scholarship program. The company operates a dedicated Ketamine Space facility in New York City and provides organizational consulting services.
Differentiator
Problem solved
Functional benefit
Products and services
- Ketamine Assisted Psychotherapy Psychedelic-assisted care combining ketamine treatment with therapeutic support, offered in individual and group session formats with live sound integration for individuals seeking psychological healing and transformation.
- Individual Ketamine Sessions One-on-one ketamine therapy sessions with personalized therapeutic support and space holding for individual clients.
- Group Ketamine Sessions (Communitas) Group ketamine ceremonies featuring live vibrational sound, art-making preparation, and post-journey integration, designed to induce communitas—an experience of community and psychological connection.
- Psilocybin Services Psilocybin-assisted therapy and preparation services for personal exploration and transformation.
- Psychedelic Preparation and Integration Coaching Coaching services to help clients prepare for and integrate psychedelic experiences, supporting psychological emergence and transformation.
- Harm Reduction Coaching Support services focused on harm reduction approaches for individuals engaged with psychedelics or dealing with addiction.
- Challenging Psychedelic Experiences Support Specialized support for individuals navigating difficult or challenging psychedelic experiences.
- Lascaux Method Facilitator Training 5-week immersive training program for psychedelic-assisted care facilitators, certifying participants in the Lascaux Method of space holding and dialogic practice, priced at $2,100.
- Coaching Certification Professional certification program for individuals seeking to become psychedelic coaches, part of Cardea's training offerings.
- Ceremonial Sound Practitioner Training Training program for individuals seeking to facilitate ceremonial sound experiences as part of psychedelic therapy.
- Organizational Support and Consulting Consulting and support services for organizations seeking to implement relational, human-focused approaches to healing and psychedelic programs.
- Jamaica Ketamine and Meditation Retreat Multi-day therapeutic retreat in Jamaica featuring dialogic sessions, sound ceremonies, yoga, art-making, and integration work with luxury beach-front accommodations; Early Bird $1,800, 3-Day Weekend $2,100.
Quantifiable outcome
- Treated over 90 frontline care professionals through Furthur Fund scholarship program
- +1 more outcomes
Companies that use Cardea
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Cardea technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cardea partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered notable, core and key.
- Ashton ApplewhitenotableAuthor of 'This Chair Rocks: A Manifesto Against Ageism' and anti-ageism activist. Hosted salon event on ending ageism. All ticket proceeds donated to Furthur Fund.
- Dr. Elias DakwarnotableAssociate Professor of Psychiatry at Columbia University and practicing psychiatrist. Hosted salon on 'The Captive Imagination' exploring relationships with psychoactive drugs and the role of imagination in psychedelic experiences.
- Hamilton MorrisnotableScientist, journalist, and documentarian known for Hamilton's Pharmacopeia. Hosted salon event 'Unveiling the Science of Ketamine' exploring ketamine's pharmacology, therapeutic uses, cultural context, and contemporary challenges.
- The Mind Bod Adventure SquadcoreCo-host of Ketamine, Meditation & Healing Retreat (postponed to March 2025). Partnership combines Cardea's psychedelic expertise with Tasha Schumann's contemplative teaching and meditation practice. Features integrated programming with group ketamine sessions, meditation, and creative exploration.
- Randy PalumbokeyPartner and designer of Cardea's Ketamine Space on Canal Street. Created the unique ambiance using reishi mushroom mycelium to craft tables, light fixtures, and window shutters. Contributed artistic vision including The Beatrice Wood Room for art-making, The Alice Coltrane Room for sound listening, Bootsy Collins Room for live sound, and the Mothership room for lectures and events.
- Dr. Andrew TatarskycoreDeveloper of Integrative Harm Reduction Psychotherapy (IHRP) model. Co-hosted 4-day experiential workshop at Cardea combining IHRP training with ketamine-assisted care. Expert in treating spectrum of addictive and compulsive behaviors.
- Eugenia BonenotableMushroom expert featured in Fantastic Fungi, journalist, chef, and author. Hosted salon 'Have A Good Trip' on magic mushrooms, their biology, use, potential and harms.
- Your Morbid FriendsnotableDeath literacy company co-hosting 'Mindfulness of Death' therapeutic group ketamine session. Provides mindfulness and somatic exercises related to death awareness before ketamine journey.
- Omega InstitutenotableHosted Planetarium: An Immersive Hi-Fidelity Sound Experience at Omega Institute in Rhinebeck, NY. Collaboration featuring sound artists from Mister Saturday Night/Mister Sunday/Nowadays.
- Aimee Meredith Cox, PhDnotableCultural anthropologist, writer, and movement artist from NYU Anthropology Department. Previously at Yale African American Studies and Anthropology. Led movement session during 'Weekend of Serious Play' workshop.
- Paul CalderónnotableWriter, actor, producer, director; faculty at NYU Tisch, Lee Strasberg Institute, School of Visual Arts, Actors Studio Drama School. Co-founded LAByrinth Theater Company. Led improvised life workshop during 'Weekend of Serious Play'.
- Margie Navarro, LAcnotableFounder of Vivacity Acupuncture, specializing in integrative sports medicine, chronic pain, and illness. Researcher on acupuncture for psychedelic integration. Co-facilitated group ketamine with acupuncture sessions.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Cardea competitors and assessment
Company assessmentBroad incumbents
- Field Trip Health: Multi-city psychedelic therapy clinic chain with ketamine and MDMA offerings that scaled significantly prior to winding down. A well-capitalized comparable that pursued the same outpatient psychedelic therapy market at much larger scale.
- Compass Pathways: Publicly listed developer of psilocybin therapy (COMP360) operating clinical trials and exploring clinic delivery. A larger incumbent in clinical psychedelic therapy pursuing a more pharmaceutical and regulator-driven pathway.
- MAPS Public Benefit Corporation: Established non-profit subsidiary developing MDMA-assisted therapy and psychedelic therapy training programs. Sits in the adjacent regulatory/training space and competes for both client relationships and practitioner mindshare.
Emerging players
- Fluence: Psychedelic therapy training company offering facilitator and clinician certification programs. Directly competes with Cardea's Lascaux Method Facilitator Training in the practitioner education market.
- Third Wave: Psychedelic education, microdosing content platform, and certification provider. Overlaps with Cardea in thought-leadership content and certification offerings for psychedelic facilitators and informed consumers.
Direct peers
- Mindbloom: At-home and clinic-based ketamine therapy provider offering physician-supervised ketamine sessions. Competes for the same client demographic seeking ketamine-assisted mental health treatment but via a remote-first delivery model.
- Nushama: NYC-based ketamine therapy clinic offering group and individual sessions with similar premium wellness positioning and target customer base. Directly comparable as a boutique ketamine therapy competitor in the same metropolitan market.
- Polaris Insight Center: Ketamine-assisted psychotherapy clinic in California focused on integration-focused therapy. Operates a similar treatment-plus-therapy model to Cardea, emphasizing preparation and integration coaching alongside ketamine sessions.
- Klarisana: Network of ketamine treatment clinics in Texas serving similar outpatient mental health use cases including depression, PTSD, and chronic pain. A directly comparable clinic-operator peer with multi-location outpatient delivery.
Regional players
- Ayahuasca Foundation: Operator of plant-medicine retreats in Peru offering guided group ceremonial experiences. Comparable as a retreat-format psychedelic therapy peer, though it operates in a different geography and traditional medicine framework.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cardea social profiles
Digital presenceCardea compliance and trust
Trust signalCompliance1 record
Cardea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cardea leadership team
Management profileNumber of profiles
Profiles4 records
Cardea funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cardea M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cardea
What does Cardea do?
Cardea is a human-centered psychedelic therapy and transformation practice that delivers ketamine-assisted psychotherapy through its proprietary Lascaux Method, offered in both individual and group formats with live vibrational sound and art-making. The practice also provides psilocybin services, psychedelic preparation and integration coaching, harm reduction coaching, facilitator training and certification programs, and organizational consulting, all anchored in a dialogic model of care.
Is Cardea a public or private company?
Cardea is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cardea founded?
Cardea was founded in 2022. It employs 1 to 10 people.
Where is Cardea based?
Cardea is headquartered in New York, United States, in the North America region.
How does Cardea make money?
Five revenue lines are on record. Ketamine-Assisted Therapy Sessions are the primary driver. The others are training and Certification Programs, retreats and Workshops, salon Series and Events and furthur Fund Scholarships.
Who are Cardea's main competitors?
Broad incumbents on record are Field Trip Health, Compass Pathways and MAPS Public Benefit Corporation. Emerging players are Fluence and Third Wave. Direct peers are Mindbloom, Nushama, Polaris Insight Center and Klarisana. Ayahuasca Foundation is listed as a regional player.
Does Cardea have an API?
No public API is recorded for Cardea.
What industry is Cardea in?
Cardea's product category is Psychedelic-Assisted Therapy Services. Its primary akta.pro industry code is HLAKABAJ, Cardiac Rehabilitation & Secondary Prevention, with a secondary code of HLAFAFAJ, Cardiac Rehabilitation Programs. Its NAICS code is 621340.